Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Symptom Burden in Head and Neck Cancer Surgery
NCT02055963Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2014
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in head and neck cancer (HNC), sponsored by University of Texas MD Anderson Cancer Center. Started May 2014; status: terminated.
02
Drugs
minocycline
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02055963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055963.